A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES

D. Sinkeviciute; A. Schlemmer; E. Berg Schmidt; A. C. Bay-Jensen; M. Karsdal; J. Hagstrup Christensen; S. Kristensen; S. Holm Nielsen

doi:10.1136/annrheumdis-2020-eular.981

A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES

D. Sinkeviciute
, A. Schlemmer
, E. Berg Schmidt
, A. C. Bay-Jensen
, M. Karsdal
, J. Hagstrup Christensen
, S. Kristensen
, S. Holm Nielsen^*

^*Corresponding author for this work

Department of Biotechnology and Biomedicine

Aalborg University
Nordic Bioscience AS

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	AB1242
Journal	Annals of the Rheumatic Diseases
Volume	79
Issue number	Suppl. 1
Pages (from-to)	1908-1909
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2020-eular.981
Publication status	Published - 2020
Event	2020 Annual European Congress of Rheumatology - Virtual event, Germany Duration: 3 Jun 2020 → 6 Jun 2020

Conference

Conference	2020 Annual European Congress of Rheumatology
Location	Virtual event
Country/Territory	Germany
Period	03/06/2020 → 06/06/2020

Access to Document

10.1136/annrheumdis-2020-eular.981

OpenUrl availability

Check availability in DTU Findit

Cite this

Sinkeviciute, D., Schlemmer, A., Schmidt, E. B., Bay-Jensen, A. C., Karsdal, M., Christensen, J. H., Kristensen, S., & Nielsen, S. H. (2020). A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES. Annals of the Rheumatic Diseases, 79(Suppl. 1), 1908-1909. Article AB1242. https://doi.org/10.1136/annrheumdis-2020-eular.981

@article{517e751d2934488dbc6b61f5cfbafee7,

title = "A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES",

author = "D. Sinkeviciute and A. Schlemmer and Schmidt, \{E. Berg\} and Bay-Jensen, \{A. C.\} and M. Karsdal and Christensen, \{J. Hagstrup\} and S. Kristensen and Nielsen, \{S. Holm\}",

year = "2020",

doi = "10.1136/annrheumdis-2020-eular.981",

language = "English",

volume = "79",

pages = "1908--1909",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "Elsevier",

number = "Suppl. 1",

note = "2020 Annual European Congress of Rheumatology, EULAR 2020 ; Conference date: 03-06-2020 Through 06-06-2020",

}

Sinkeviciute, D, Schlemmer, A, Schmidt, EB, Bay-Jensen, AC, Karsdal, M, Christensen, JH, Kristensen, S & Nielsen, SH 2020, 'A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, AB1242, pp. 1908-1909. https://doi.org/10.1136/annrheumdis-2020-eular.981

A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES. / Sinkeviciute, D.; Schlemmer, A.; Schmidt, E. Berg et al.
In: Annals of the Rheumatic Diseases, Vol. 79, No. Suppl. 1, AB1242, 2020, p. 1908-1909.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - A NOVEL BIOMARKER OF MMP-CLEAVED PROLARGIN IS ELEVATED IN PATIENTS WITH PSORIATIC ARTHRITIS COMPARED TO OTHER FIBRO-INFLAMMATORY DISEASES

AU - Sinkeviciute, D.

AU - Schlemmer, A.

AU - Schmidt, E. Berg

AU - Bay-Jensen, A. C.

AU - Karsdal, M.

AU - Christensen, J. Hagstrup

AU - Kristensen, S.

AU - Nielsen, S. Holm

PY - 2020

Y1 - 2020

U2 - 10.1136/annrheumdis-2020-eular.981

DO - 10.1136/annrheumdis-2020-eular.981

M3 - Conference abstract in journal

SN - 0003-4967

VL - 79

SP - 1908

EP - 1909

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl. 1

M1 - AB1242

T2 - 2020 Annual European Congress of Rheumatology

Y2 - 3 June 2020 through 6 June 2020

ER -